{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:53:30Z","timestamp":1784055210759,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.06.025","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T09:12:14Z","timestamp":1467105134000},"page":"325-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries"],"prefix":"10.1016","volume":"111","author":[{"given":"Nicola","family":"Kahlberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarryd","family":"Anthonisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwina","family":"Jap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi Hooi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jelinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Kemp-Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Huei","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.06.025_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.06.025_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"De Vriese","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2014.12.023","article-title":"Arterial stiffness in diabetes mellitus","volume":"238","author":"Prennerand","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.06.025_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan-and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0030","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s001250051564","article-title":"Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin","volume":"43","author":"Elsner","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0035","first-page":"2786","article-title":"Alkylation of DNA in rat tissues following administration of streptozotocin","volume":"41","author":"Bennettand","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.06.025_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2010.03.048","article-title":"Reactive oxygen species and endothelial function in diabetes","volume":"636","author":"Fatehi-Hassanabad","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1476-5381.2010.01023.x","article-title":"Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes","volume":"162","author":"Leo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0703354","article-title":"Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat","volume":"130","author":"Makino","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0055","doi-asserted-by":"crossref","first-page":"H283","DOI":"10.1152\/ajpheart.00954.2002","article-title":"Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats","volume":"285","author":"Matsumoto","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0060","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-004-1411-x","article-title":"Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-\u03b2 in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats","volume":"47","author":"Wigg","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00125-007-0918-3","article-title":"Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease","volume":"51","author":"Stehouwer","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/physiol.00029.2008","article-title":"The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure","volume":"24","author":"Martinez-Lemus","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.phrs.2016.06.025_bib0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.06.025_bib0080","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI119229","article-title":"Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products","volume":"99","author":"Rumble","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.06.025_bib0085","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","article-title":"Mechanisms, pathophysiology, and therapy of arterial stiffness","volume":"25","author":"Zieman","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jprot.2013.05.012","article-title":"Protein glycation during aging and in cardiovascular disease","volume":"92","author":"Simm","year":"2013","journal-title":"J. Proteom."},{"key":"10.1016\/j.phrs.2016.06.025_bib0095","doi-asserted-by":"crossref","first-page":"H69","DOI":"10.1152\/ajpheart.00341.2008","article-title":"Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1\/2 MAP kinase \u03b1v\u03b23-integrin, and TGF-\u03b21 in response to ANG II and high glucose","volume":"295","author":"Belmadani","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0100","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/diab.43.10.1221","article-title":"Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition","volume":"43","author":"Cooper","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.06.025_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diabres.2005.03.038","article-title":"Diabetes induces Na\/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries","volume":"70","author":"Dilley","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2016.06.025_bib0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/FJC.0000000000000180","article-title":"Flavonols in the prevention of diabetes-induced vascular dysfunction","volume":"65","author":"Leoand","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/abbi.1995.1231","article-title":"NO+ NO., and NO-donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation","volume":"318","author":"Arnelleand","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2016.06.025_bib0120","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1073\/pnas.91.23.10992","article-title":"Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase","volume":"91","author":"Hobbs","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.06.025_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj3320009","article-title":"Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite","volume":"332","author":"Sharpeand","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.phrs.2016.06.025_bib0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.2009.00150.x","article-title":"A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries","volume":"157","author":"Andrews","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0135","article-title":"Nitroxyl (HNO) as a vasoprotective signaling molecule","volume":"1675","author":"Bullen","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.06.025_bib0140","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","article-title":"Redox variants of NO (NO\u00b7 and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms","volume":"296","author":"Favaloroand","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0145","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.06.025_bib0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phrs.2012.07.010","article-title":"Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta","volume":"66","author":"Leo","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.06.025_bib0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0003-9861(02)00031-0","article-title":"Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite","volume":"401","author":"Miranda","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2016.06.025_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2011.03.018","article-title":"3',4'-Dihydroxyflavonol restores endothelium dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes","volume":"659","author":"Leo","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.phrs.2016.03.011","article-title":"Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta","volume":"107","author":"Ng","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.06.025_bib0170","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2337\/diabetes.52.9.2389","article-title":"B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP","volume":"52","author":"Rosenkranz","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.06.025_bib0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1096\/fj.13-233429","article-title":"Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment","volume":"28","author":"Jelinic","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.06.025_bib0180","doi-asserted-by":"crossref","first-page":"e107382","DOI":"10.1371\/journal.pone.0107382","article-title":"A vasoactive role for endogenous relaxin in mesenteric arteries of male mice","volume":"9","author":"Leo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.025_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11357-015-9803-z","article-title":"Differential effects of relaxin deficiency on vascular aging in arteries of male mice","volume":"37","author":"Jelinic","year":"2015","journal-title":"Age"},{"key":"10.1016\/j.phrs.2016.06.025_bib0190","doi-asserted-by":"crossref","first-page":"e000493","DOI":"10.1161\/JAHA.113.000493","article-title":"Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation","volume":"3","author":"Leo","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2016.06.025_bib0195","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/bph.13404","article-title":"Time-dependent activation of prostacyclin and nitric oxide pathways during continuous intravenous infusion of serelaxin (recombinant human H2 relaxin)","volume":"173","author":"Leo","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0200","doi-asserted-by":"crossref","first-page":"e20813","DOI":"10.1371\/journal.pone.0020813","article-title":"3',4'-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries","volume":"6","author":"Leo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.025_bib0205","doi-asserted-by":"crossref","first-page":"H232","DOI":"10.1152\/ajpheart.2001.281.1.H232","article-title":"Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery","volume":"281","author":"Wigg","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0210","first-page":"639","article-title":"Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus","volume":"49","author":"Haughton","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.phrs.2016.06.025_bib0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-9150(00)00583-9","article-title":"Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats","volume":"155","author":"Kobayashiand","year":"2001","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.phrs.2016.06.025_bib0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000320627","article-title":"Vascular dysfunction in streptozotocin-induced experimental diabetes strictly depends on insulin deficiency","volume":"48","author":"Oelze","year":"2011","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.phrs.2016.06.025_bib0225","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness","volume":"1318","author":"Vlachopoulos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0230","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/BF00274536","article-title":"Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus","volume":"32","author":"Oxlund","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0235","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/bph.12656","article-title":"Effects of a new advanced glycation inhibitor LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis","volume":"171","author":"Satheesan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0240","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2337\/diab.43.12.1450","article-title":"Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats: effect of aminoguanidine treatment","volume":"43","author":"Hilland","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.06.025_bib0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1139\/y96-082","article-title":"Arterial remodeling: relation to hemodynamics","volume":"74","author":"Langille","year":"1996","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0250","article-title":"Alterations in distribution of cardiac output in experimental diabetes in rats","volume":"H571","author":"Hilland","year":"1989","journal-title":"Am. J. Physiol. (USA)"},{"key":"10.1016\/j.phrs.2016.06.025_bib0255","article-title":"Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling","volume":"1672","author":"Crijns","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0260","doi-asserted-by":"crossref","first-page":"H1699","DOI":"10.1152\/ajpheart.1997.273.4.H1699","article-title":"Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow","volume":"273","author":"Pourageaudand","year":"1997","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0265","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0895-7061(97)00311-7","article-title":"Vascular compliance and cardiovascular disease: a risk factor or a marker?","volume":"10","author":"Glasser","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2016.06.025_bib0270","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/diacare.24.12.2102","article-title":"Vascular compliance is reduced in the early stages of type 1 diabetes","volume":"24","author":"Romneyand","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.06.025_bib0275","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/dmrr.1040","article-title":"Subclinical vascular alterations in young adults with type 1 diabetes detected by arterial tonometry","volume":"25","author":"Barchetta","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.phrs.2016.06.025_bib0280","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.bjp.0701258","article-title":"Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats","volume":"121","author":"Fukao","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s001250051140","article-title":"Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration","volume":"42","author":"Pieper","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.06.025_bib0290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.1996.tb15699.x","article-title":"The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat","volume":"119","author":"Heygate","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0295","doi-asserted-by":"crossref","first-page":"H502","DOI":"10.1152\/ajpheart.01197.2009","article-title":"Short term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery","volume":"299","author":"Leo","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0300","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-199611000-00014","article-title":"The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation","volume":"28","author":"Shimokawa","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0305","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00424-010-0817-1","article-title":"Endothelium-derived hyperpolarising factors and associated pathways: a synopsis","volume":"459","author":"Edwards","year":"2010","journal-title":"Pflug. Arch.\u2fffEur. J. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20140759","article-title":"Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance","volume":"129","author":"Andrews","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2016.06.025_bib0315","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/bph.12568","article-title":"The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and-independent mechanisms","volume":"171","author":"Chin","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0320","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.06.025_bib0325","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2016.06.025_bib0330","doi-asserted-by":"crossref","first-page":"33554","DOI":"10.1074\/jbc.M004337200","article-title":"Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase","volume":"275","author":"Adak","year":"2000","journal-title":"Implic. Mech. J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.06.025_bib0335","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00630.2012","article-title":"Nitroxyl donors retain their depressor effects in hypertension","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0340","doi-asserted-by":"crossref","first-page":"H1405","DOI":"10.1152\/ajpheart.00489.2011","article-title":"Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia","volume":"301","author":"Bullen","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0345","doi-asserted-by":"crossref","first-page":"H365","DOI":"10.1152\/ajpheart.00495.2012","article-title":"HNO\/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO\u033f","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.025_bib0350","doi-asserted-by":"crossref","first-page":"e34892","DOI":"10.1371\/journal.pone.0034892","article-title":"Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.025_bib0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","article-title":"Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity","volume":"60","author":"Miller","year":"2013","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.phrs.2016.06.025_bib0360","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCHEARTFAILURE.114.001699","article-title":"Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus In vivo","volume":"8","author":"Cao","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2016.06.025_bib0365","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1089\/ars.2011.3937","article-title":"Nitroxyl (HNO): a novel redox signaling molecule","volume":"14","author":"Kemp-Harper","year":"2011","journal-title":"Antioxid. Redox Signal."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T01:32:56Z","timestamp":1531618376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816301773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":73,"alternative-id":["S1043661816301773"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.025","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}